Characteristic | Healthy control group | Type 2 diabetes DPN patient group | ||||||||||
Age group 1 | Age group 2 | Age group 3 | Age group 1 | Age group 2 | Age group 3 | |||||||
Male/female (n) | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
Age (years) | 44.6±1.8 | 45.9±1.8 | 55±3.2 | 54.4±2.7 | 63.6±2.3 | 65.8±2.1 | 44.9±2.8 | 45.5±1.8 | 55±2.2 | 54.1±2.5 | 64.1±3.2 | 62.3±1.9 |
Height (cm) | 176±6.5 | 162±6.7 | 173±6.6 | 163±6.9 | 173±6.7 | 167±10.1 | 173±6.7 | 164±7.4 | 177±5.2 | 166±4.8 | 174±4.3 | 166±6.4 |
Weight (kg) | 66±5.2 | 56±5.0 | 69.9±6.2 | 56.8±7.1 | 68.9±5.5 | 64.5±9.6 | 67.3±8.0 | 59.5±7.2 | 71.6±4.5 | 65.6±4.3 | 68.6±6.3 | 64.8±4.6 |
BMI (kg/m2) | 21.4±2.1 | 21.3±1.0 | 23.3±1.0 | 21.4±1.6 | 23.0±1.0 | 23.0±1.3 | 22.3±1.6 | 22.1±1.8 | 22.9±1.1 | 23.7±0.3 | 22.7±1.3 | 23.4±0.5 |
Duration of diabetes | N | N | N | N | N | N | 4±3 | 4±2.2 | 7.4±4.3 | 6.2±3.1 | 14±9 | 14.3±7.2 |
Systolic BP (mm Hg) | 119±10 | 113±9 | 121±11 | 125±13 | 123±16 | 122±12 | 118±7 | 116±4 | 124±8 | 120±5 | 125±3 | 125±4 |
Diastolic BP (mm Hg) | 80±5 | 77±8 | 82±4 | 83±5 | 85±4 | 85±2 | 82±3 | 76±5 | 81±5 | 80±3 | 85±3 | 83±4 |
HbA1c (%) | 4.7±0.6 | 4.5±0.4 | 5.2±0.3 | 5.3±0.6 | 5.3±0.5 | 5.4±0.3 | 7.3±0.3 | 7.4±0.3 | 8.1±0.3 | 7.9±0.7 | 8.6±0.4 | 8.4±0.5 |
Low-Density Lipoprotein Cholesterol (mmol/L) | 2.19±0.5 | 2.4±0.6 | 2.53±0.4 | 2.63±0.2 | 3.02±0.5 | 2.93±0.7 | 2.73±0.8 | 2.66±0.6 | 3.1±0.4 | 3.02±0.4 | 3.08±0.3 | 3.08±0.5 |
TCSS | N | N | N | N | N | N | 6.7±0.5 | 6.8±0.4 | 7.6±0.3 | 7.4±0.4 | 7.8±0.2 | 7.7±0.2 |
Values are expressed as means±SD.
'N' means no duration of diabetes.
BMI, body mass index; BP, blood pressure; DPN, diabetic peripheral neuropathy; TCSS, Toronto Clinical Scoring System.